XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 28, Issue 3, 2006, Pages 196-199

  Yuan, Peng ^a   Miao, Xiao ping ^a   Zhang, Xue mei ^a   Wang, Zhong hua ^a   Tan, Wen ^a   Sun, Yan ^a   Zhang, Xiang ru ^a   Xu, Bing he ^a   Lin, Dong xin ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DNA BINDING PROTEIN; DRUG DERIVATIVE; ERCC2 PROTEIN, HUMAN; NAVELBINE; PACLITAXEL; VINBLASTINE; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ADULT; AGED; ARTICLE; DNA REPAIR; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; REMISSION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; POLYMORPHISM, GENETIC; REMISSION INDUCTION; VINBLASTINE; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 38049091607     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)